Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Block

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Cancer Research|June 14, 2018
Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma PatientsLei Wang, Sara J Felts, Virginia P Van Keulen, et al.
Oncology|January 19, 2016
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian CancerAminah Jatoi, Robert A Vierkant, Kieran M Hawthorne, et al.
Cytokine|March 7, 2015
Plasma immune analytes in patients with epithelial ovarian cancerMatthew S Block, Matthew J Maurer, Krista Goergen, et al.
American Journal of Clinical Oncology|October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian CancerAminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2013
Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancerAaron M Carlson, Matthew J Maurer, Krista M Goergen, et al.
Melanoma Research|February 6, 2016
The use of pembrolizumab for the treatment of metastatic uveal melanomaLisa A Kottschade, Robert R McWilliams, Svetomir N Markovic, et al.
Journal of Clinical Medicine|November 25, 2023
Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 InfectionBalaji Pathakumari, Paige K Marty, Maleeha Shah, et al.
Journal of Gastrointestinal Cancer|April 27, 2025
Multidisciplinary Management of Anorectal Melanoma: a Retrospective Analysis of Surgical and Systemic Therapies from the National Cancer DatabaseRichard Sassun, Annaclara Sileo, Jyi Cheng Ng, et al.
International Journal of Cancer|April 21, 2026
Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated MelanomaRonen Stoff, Gokce Belge Bilgin, Yalda Nikanpour, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2016
The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteinsZheng Li, Matthew S Block, Robert A Vierkant, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Cancer Research|June 14, 2018
Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma PatientsLei Wang, Sara J Felts, Virginia P Van Keulen, et al.
Oncology|January 19, 2016
Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian CancerAminah Jatoi, Robert A Vierkant, Kieran M Hawthorne, et al.
Cytokine|March 7, 2015
Plasma immune analytes in patients with epithelial ovarian cancerMatthew S Block, Matthew J Maurer, Krista Goergen, et al.
American Journal of Clinical Oncology|October 20, 2025
A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian CancerAminah Jatoi, Nathan R Foster, Andrea Wahner Hendrickson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2013
Utility of progranulin and serum leukocyte protease inhibitor as diagnostic and prognostic biomarkers in ovarian cancerAaron M Carlson, Matthew J Maurer, Krista M Goergen, et al.
Melanoma Research|February 6, 2016
The use of pembrolizumab for the treatment of metastatic uveal melanomaLisa A Kottschade, Robert R McWilliams, Svetomir N Markovic, et al.
Journal of Clinical Medicine|November 25, 2023
Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 InfectionBalaji Pathakumari, Paige K Marty, Maleeha Shah, et al.
Journal of Gastrointestinal Cancer|April 27, 2025
Multidisciplinary Management of Anorectal Melanoma: a Retrospective Analysis of Surgical and Systemic Therapies from the National Cancer DatabaseRichard Sassun, Annaclara Sileo, Jyi Cheng Ng, et al.
International Journal of Cancer|April 21, 2026
Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated MelanomaRonen Stoff, Gokce Belge Bilgin, Yalda Nikanpour, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 28, 2016
The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteinsZheng Li, Matthew S Block, Robert A Vierkant, et al.
Pageof 12